Every SEC Form 3/4/5 on record for this filer (CIK 1365493) — 8 issuers, 29 transactions. Section-16 filings only: what they filed, not a biography, and titles are as filed on their latest form at each issuer.
| Ticker | Company | Role as filed | On file | Forms | Open-market net |
|---|---|---|---|---|---|
| QDEL | QuidelOrtho Corp | Director | 2024-12-10 → 2026-06-29 | 5 | — |
| NPCE | NeuroPace Inc | Director | 2025-01-08 → 2026-06-05 | 4 | — |
| NVST | Envista Holdings Corp | Director | 2019-09-20 → 2026-05-21 | 8 | — |
| HYPR | Hyperfine, Inc. | Director · lapsed | 2021-12-23 → 2024-06-12 | 8 | — |
| NUVA | NUVASIVE INC | Director · lapsed | 2018-10-03 → 2023-09-05 | 8 | — |
| AFIB | Acutus Medical, Inc. | Director · lapsed | 2020-08-05 → 2023-06-15 | 5 | −$34,800 |
| VRAY | ViewRay, Inc. | Director · lapsed | 2018-03-05 → 2020-06-17 | 8 | — |
| GI | EndoChoice Holdings, Inc. | Director · lapsed | 2015-08-17 → 2016-11-23 | 3 | — |
No open-market buy or sale on record — only grants, exercises, withholding or gifts. Switch to “All forms” to see them.
4 of 8 issuers are covered and open a security page; the rest are on file here only.
